| Literature DB >> 20625495 |
Lunbiao Cui1, Xiling Guo, Yuhua Qi, Xian Qi, Yiyue Ge, Zhiyang Shi, Tao Wu, Jun Shan, Yunfeng Shan, Zheng Zhu, Hua Wang.
Abstract
Role of microRNA (miRNA) has been highlighted in pathogen-host interactions recently. To identify cellular miRNAs involved in the host response to enterovirus 71 (EV71) infection, we performed a comprehensive miRNA profiling in EV71-infected Hep2 cells through deep sequencing. 64 miRNAs were found whose expression levels changed for more than 2-fold in response to EV71 infection. Gene ontology analysis revealed that many of these mRNAs play roles in neurological process, immune response, and cell death pathways, which are known to be associated with the extreme virulence of EV71. To our knowledge, this is the first study on host miRNAs expression alteration response to EV71 infection. Our findings supported the hypothesis that certain miRNAs might be essential in the host-pathogen interactions.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20625495 PMCID: PMC2896697 DOI: 10.1155/2010/425939
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Number of reads of miRNAs from EV71 infected and non-infected Hep2 cells.
| Infected cells | Control cells | |
|---|---|---|
| High quality/both adapter | 35,272 | 78,143 |
| Exact match to known human miRNAs | 2,731 | 8,457 |
| Loose match to known human miRNAs | 20,389 | 47,652 |
Figure 1Size distribution of sequenced short RNAs.
Upexpressed miRNAs in infected cells compared with non-infected cells.
| miRNA | Reads in infected | Reads in non-infected | Z score | Ratio infected/non-infected (Normalized) |
|---|---|---|---|---|
| hsa-mir-636 | 11 | 0 | 5.05958439 | # |
| hsa-mir-619 | 305 | 41 | 23.59443534 | 17.31099765 |
| hsa-mir-1302-8 | 387 | 54 | 26.46428291 | 16.67720702 |
| hsa-mir-1302-2 | 1560 | 228 | 53.05155216 | 15.92193571 |
| hsa-mir-1302-6,7 | 387 | 57 | 26.28151611 | 15.79945928 |
| hsa-mir-1302-3 | 390 | 58 | 26.34977656 | 15.64741958 |
| hsa-mir-1302-1 | 366 | 59 | 25.24116716 | 14.4356116 |
| hsa-mir-1302-5 | 305 | 50 | 22.98061978 | 14.19501807 |
| hsa-mir-1302-4 | 300 | 50 | 22.73564953 | 13.96231285 |
| hsa-mir-1273 | 162 | 37 | 15.80907527 | 10.18871479 |
| hsa-mir-1290 | 34 | 8 | 7.194848151 | 9.889971606 |
| hsa-mir-1268 | 17 | 4 | 5.08718048 | 9.889971606 |
| hsa-mir-1178 | 11 | 3 | 3.959263353 | 8.532524522 |
| hsa-mir-1246 | 382 | 121 | 22.48247616 | 7.346561309 |
| hsa-mir-1972 | 34 | 12 | 6.488332484 | 6.593314404 |
| hsa-mir-1285-1 | 96 | 35 | 10.79491649 | 6.382771591 |
| hsa-mir-566 | 13 | 5 | 3.901900612 | 6.05033557 |
| hsa-mir-1226 | 10 | 4 | 3.376339014 | 5.817630356 |
| hsa-mir-635 | 12 | 5 | 3.645008994 | 5.584925142 |
| hsa-mir-627 | 16 | 7 | 4.132798028 | 5.318976326 |
| hsa-mir-518c | 13 | 6 | 3.647443806 | 5.041946309 |
| hsa-mir-1185-2 | 20 | 10 | 4.373804587 | 4.654104285 |
| hsa-mir-1289-1 | 14 | 7 | 3.659280977 | 4.654104285 |
| hsa-mir-539 | 11 | 6 | 3.116008646 | 4.266262261 |
| hsa-mir-1247 | 18 | 10 | 3.95066374 | 4.188693856 |
| hsa-mir-764 | 12 | 7 | 3.147056335 | 3.989232244 |
| hsa-mir-1979 | 330 | 201 | 16.15562506 | 3.820533368 |
| hsa-mir-1272 | 11 | 7 | 2.873705427 | 3.656796224 |
| hsa-mir-324 | 28 | 18 | 4.558616136 | 3.619858888 |
| hsa-mir-1975 | 829 | 548 | 24.5078521 | 3.520303332 |
| hsa-mir-744 | 28 | 19 | 4.414239693 | 3.429339999 |
| hsa-mir-541 | 19 | 16 | 3.126630669 | 2.763374419 |
| hsa-mir-1254 | 13 | 11 | 2.576283222 | 2.750152532 |
| hsa-mir-421 | 42 | 38 | 4.379270931 | 2.572005 |
| hsa-mir-1237 | 11 | 10 | 2.231381474 | 2.559757357 |
| hsa-mir-320c-1 | 74 | 77 | 5.081196578 | 2.236387773 |
| hsa-mir-615 | 16 | 17 | 2.309101549 | 2.190166722 |
| hsa-mir-720 | 14 | 15 | 2.140061026 | 2.171915333 |
| hsa-mir-140 | 184 | 208 | 7.299247353 | 2.058546126 |
| hsa-mir-451 | 188 | 214 | 7.31642594 | 2.044326181 |
| hsa-mir-21 | 3445 | 3992 | 31.35678948 | 2.008190038 |
Down-expressed miRNAs in infected cells compared with non-infected cells.
| miRNA | Reads in infected | Reads in non-infected | Z score | Ratio infected/non-infected (Normalized) |
|---|---|---|---|---|
| hsa-mir-584 | 0 | 10 | −2.07306 | 0 |
| hsa-mir-221 | 4 | 70 | −4.6261 | 0.132974 |
| hsa-let-7e | 23 | 199 | −6.40515 | 0.268956 |
| hsa-mir-1180 | 5 | 43 | −2.96815 | 0.270587 |
| hsa-mir-1259 | 6 | 46 | −2.91293 | 0.303529 |
| hsa-mir-338 | 128 | 905 | −12.4248 | 0.32913 |
| hsa-mir-30a | 304 | 2083 | −18.6008 | 0.339618 |
| hsa-mir-19b-1 | 487 | 2952 | −20.5604 | 0.383901 |
| hsa-mir-19b-2 | 491 | 2946 | −20.3931 | 0.387842 |
| hsa-mir-545 | 7 | 41 | −2.33845 | 0.397302 |
| hsa-mir-433 | 6 | 35 | −2.15407 | 0.398923 |
| hsa-mir-582 | 93 | 531 | −8.27217 | 0.407563 |
| hsa-mir-26a-1 | 129 | 735 | −9.72425 | 0.408421 |
| hsa-mir-26a-2 | 132 | 746 | −9.73602 | 0.411757 |
| hsa-mir-27b | 123 | 677 | −9.08034 | 0.422788 |
| hsa-mir-452 | 31 | 158 | −4.09666 | 0.456574 |
| hsa-mir-1974 | 38 | 188 | −4.34508 | 0.470362 |
| hsa-mir-27a | 280 | 1382 | −11.8087 | 0.471472 |
| hsa-mir-26b | 35 | 172 | −4.12863 | 0.473528 |
| hsa-mir-30e | 86 | 419 | −6.39521 | 0.477629 |
| hsa-mir-222 | 50 | 236 | −4.64215 | 0.49302 |
| hsa-mir-660 | 48 | 225 | −4.4992 | 0.496438 |
Figure 2Predicted targets gene ontology terms in the biological process category.
Reverse regulatory association of up-regulated miRNAs and their predicted mRNA targets.
| Up-regulated miRNA | Target genes | Functions | Reference | ||
|---|---|---|---|---|---|
| hsa-mir-1289-1 | Interferon regulatory factor 2 | IFN response | [ | ||
| hsa-mir-140,hsa-mir-320c | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | Oncogene | [ | ||
| hsa-mir-421 | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | [ | |||
| hsa-mir-1226 | Interleukin 10 receptor, beta | Immune response | [ | ||
| hsa-mir-1290 | Nuclear receptor coactivator 2 | Transcriptional regulators | [ | ||
| hsa-mir-320c,hsa-mir-1290 | Transcription factor AP-2 beta | [ | |||
| hsa-mir-320c | pre-B-cell leukemia homeobox 3 | [ | |||
| hsa-mir-636,hsa-miR-1979,hsa-mir-1302,hsa-mir-518c,hsa-mir-1226,hsa-mir-1290,hsa-mir-421,hsa-mir-21,hsa-mir-140 | ribosomal protein S6 kinase | Kinases and phosphatases | [ | ||
| hsa-mir-1289-1,hsa-mir-1272,hsa-mir-421 | Splicing factor, arginine/serine-rich 1 | RNA synthesis and modification | [ | ||
| hsa-mir-1272,hsa-mir-140,hsa-mir-636 | Neuro-oncological ventral antigen 1 | Neuron specific | [ | ||
| hsa-mir-539 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | [ | |||
| hsa-mir-1254,hsa-mir-627,hsa-mir-320c,hsa-mir-421,hsa-mir-21,hsa-mir-140 | cyclin-dependent kinase 6 | cell cycle | [ | ||
| hsa-mir-619 | protocadherin 9 | cell adhesion | [ | ||
| hsa-mir-627 | RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae) | trafficking and targeting proteins | [ | ||
| hsa-mir-140 | sorting nexin 2 | [ | |||
| hsa-mir-1289-1 | xenotropic and polytropic retrovirus receptor | Cellular receptors | [ | ||
| hsa-mir-21 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | cell signalling, extracellular communication | [ | ||
| hsa-mir-1178,hsa-mir-140 | transforming growth factor, alpha | [ | |||
| hsa-mir-1178 | dual specificity phosphatase 6 | intracellular trasducers/effector/modulators | [ | ||
Reverse regulatory association of down-regulated miRNAs and their predicted mRNA targets.
| Down-regulated miRNA | Target genes | Functions | Reference |
|---|---|---|---|
| hsa-mir-27 | Cytochrome P450,superfamily I polypeptide 1 | Mitochondrial function | [ |
| hsa-mir-26a,hsa-mir-27 | BCL2-antagonist/killer 1 | Apoptosis | [ |
| hsa-mir-26a | Programmed cell death 10 | [ | |
| hsa-mir-582 | Amyloid beta (A4) precursor protein | [ | |
| hsa-mir-19 | BCL2-associated athanogene 5 | [ | |
| hsa-mir-1180,hsa-mir-19,hsa-mir-582,hsa-mir-26a,hsa-mir-30a,hsa-let-7e,hsa-mir-545 | calcium channel, voltage-dependent, L type, alpha 1C subunit | Membrane transporters | [ |
| hsa-mir-433,hsa-let-7e | Cathepsin C | Protein degradation | [ |
| hsa-mir-26a,hsa-mir-545 | Muscle RAS oncogene homolog | Oncogene | [ |
| hsa-mir-19 | RAB5B, member RAS oncogene family | [ | |
| hsa-mir-19 | neurotrophic tyrosine kinase, receptor, type 2 | Kinases and phosphatases | [ |
| hsa-mir-19 | Fas-activated serine/threonine kinase | [ | |
| hsa-mir-582,hsa-let-7e | adaptor-related protein complex 1, sigma 1 subunit | trafficking and targeting proteins | [ |
| hsa-mir-27 | actin, alpha 2, smooth muscle, aorta | cytoskeleton/motility | [ |